Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis

被引:15
|
作者
Dratwa, M
Wilkie, M
Ryckelynck, JP
ter Wee, PM
Rutherford, P
Michel, C
Hopwood, A
Curtis, L
Denys, N
Divino, JC
Faict, D
机构
[1] CHU Brugmann, Brussels, Belgium
[2] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England
[3] CHU Clemenceau, Caen, France
[4] Free Univ Amsterdam, Acad Ziekenhuis, NL-1007 MC Amsterdam, Netherlands
[5] NE Wales NHS Trust, Wrexham, Clwyd, Wales
[6] Hop Bichat, F-75877 Paris, France
[7] Baxter Healthcare Corp, Brussels, Belgium
关键词
acidosis; alkalosis; bicarbonate; biocompatibility; lactate; peritoneal dialysis; bicarbonate/lactate; calcium; APD; buffer;
D O I
10.1046/j.1523-1755.2003.08812.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Patients on automated peritoneal dialysis (APD) usually receive larger volumes of dialysis solution and more frequent, shorter exchanges than patients on continuous ambulatory peritoneal dialysis (CAPD), and therefore are likely to derive greater benefit from more physiologic solutions. Methods. Peritoneal dialysis solutions containing 25 mmol/L bicarbonate and either 10 or 15 mmol/L lactate were compared with standard lactate solutions (35 or 40 mmol/L) in two prospective, open-label studies of patients on APD. Each study included a 2-week baseline period (lactate solution), a 6-week treatment period (bicarbonate/lactate solution), and a 2-week follow-up period (same lactate solution as baseline). Biochemical analyses and assessments of vital signs and safety parameters were conducted at baseline, every 2 weeks during treatment, and at the end of the follow-up period. A product use questionnaire was administered in one study at the end of treatment. Results. A statistically significant rise in plasma bicarbonate (approximately 2 mmol/L) occurred when patients switched from a lactate solution to the bicarbonate/lactate solution with equimolar buffer concentration (P<0.001 for each solution). Plasma bicarbonate decreased by 1.16 mmol/L after a switch from lactate 40 mmol/L to bicarbonate/lactate 35 mmol/L (P<0.001). When patients switched to bicarbonate/lactate 35, the majority of individual venous plasma bicarbonate values were in the normal range. A switch from a lower calcium (1.25 mmol/L) lactate solution to a higher calcium (1.75 mmol/L) lactate/bicarbonate solution resulted in a statistically significant rise in serum calcium (0.06 mmol/L, P<0.018). The product use questionnaire revealed improvements in symptoms, including reduced pain on infusion. Conclusion. Bicarbonate/lactate solutions may be used safely and effectively in patients on APD. The availability of 2 formulations with different buffer and calcium content provides flexibility for the control of acidosis as well as calcium balance.
引用
收藏
页码:S105 / S113
页数:9
相关论文
共 50 条
  • [21] CLINICAL-EXPERIENCE WITH HOME AUTOMATED PERITONEAL-DIALYSIS
    BRUNKHORST, R
    WRENGER, E
    KRAUTZIG, S
    EHLERDING, G
    MAHIOUT, A
    KOCH, KM
    KIDNEY INTERNATIONAL, 1994, : S25 - S30
  • [22] Bicarbonate buffers in peritoneal dialysis
    Passlick-Deetjen, J
    Jaeckle-Meyer, I
    ARTIFICIAL ORGANS, 1998, 22 (01) : 17 - 19
  • [23] Bicarbonate versus lactate buffer in peritoneal dialysis solutions: The beneficial effect on RBC metabolism
    Buoncristiani, U
    Galli, F
    Rovidati, S
    Albertini, MC
    Covarelli, C
    Carobi, C
    DiPaolo, N
    Canestrari, F
    PERITONEAL DIALYSIS INTERNATIONAL, 1996, 16 (05): : 511 - 518
  • [24] LACTATE-CONTAINING VERSUS BICARBONATE-CONTAINING PERITONEAL-DIALYSIS SOLUTIONS
    ING, TS
    ZHOU, XJ
    YU, AW
    VAZIRI, ND
    PERITONEAL DIALYSIS INTERNATIONAL, 1992, 12 (03): : 276 - 277
  • [25] LACTATE-BASED VERSUS BICARBONATE-BASED PERITONEAL-DIALYSIS SOLUTIONS
    PEDERSEN, FB
    PERITONEAL DIALYSIS INTERNATIONAL, 1995, 15 (07): : S47 - S51
  • [26] Rapid initiation of peritoneal dialysis by automated peritoneal dialysis or hemodialysis: a randomized clinical trial
    Zhang, Qianying
    Wu, Pei
    Xie, Jingyuan
    Li, Xiao
    Xu, Tian
    Huang, Xiaomin
    Zhang, Chunyan
    Chen, Nan
    Ren, Hong
    KIDNEY DISEASES, 2023, 9 (06) : 529 - 537
  • [27] In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function
    Topley, N
    Kaur, D
    Petersen, MM
    Jorres, A
    Williams, JD
    Faict, D
    Holmes, CJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (02): : 218 - 224
  • [28] A BIOCOMPATIBILITY COMPARISON OF BICARBONATE VERSUS BICARBONATE-LACTATE BASED SOLUTIONS FOR PERITONEAL-DIALYSIS (PD)
    HOLMES, CJ
    TOPLEY, N
    KAUR, D
    PETERSEN, MM
    JORRES, A
    FAICT, D
    WILLIAMS, JD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 453 - 453
  • [29] Automated peritoneal dialysis
    Rodríguez-Carmona, A
    NEFROLOGIA, 2000, 20 : 46 - 52
  • [30] Is automated peritoneal dialysis a superior form of peritoneal dialysis.
    Anijeet, HKI
    Rustom, R
    Livesley, P
    Bell, BM
    Ahmad, R
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2596 - 2596